Press Releases

May 15, 2019
The launch of Covetrus creates a new global market leader in technology and services in animal health to drive new health and financial outcomes for veterinarians and their clients   Revenue of $941 million down 1% year-over-year, non-GAAP pro forma revenue of $965 million up 3% year-over-year on
May 6, 2019
Veterinarians to Benefit from Covetrus’ Multi-Channel Capabilities PORTLAND, Maine --(BUSINESS WIRE)--May 6, 2019-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced a new partnership with Mars Petcare that will help U.S.-based veterinarians enhance
February 8, 2019
A global leader in the animal health industry begins trading on Nasdaq Stock Market PORTLAND, Maine , Feb. 08, 2019 (GLOBE NEWSWIRE) -- Today, Covetrus (NASDAQ:CVET) celebrates the combination of two unique and complementary businesses – Henry Schein Animal Health and Vets First Choice – as a newly
February 6, 2019
PORTLAND, Maine--( BUSINESS WIRE )--Vets First Choice and Covetrus, a global animal-health technology and services company empowering veterinary practices that will result from the expected spin-off and merger of the Henry Schein Animal Health business with Vets First Choice, today announced that
January 23, 2019
PORTLAND, ME, January 23, 2019 – Vets First Choice today announced that Covetrus, the new, standalone public company that will result from the planned spin-off of the Henry Schein Animal Health business and the subsequent merger with Vets First Choice, will host its 2019 Capital Markets Day on
January 14, 2019
David E. Shaw to serve as Chairman of the Board; Philip Laskawy to serve as Lead Independent Director MELVILLE, N.Y., and PORTLAND, ME, January 14, 2019 – Henry Schein, Inc. (Nasdaq: HSIC) and Vets First Choice today announced their designees who will comprise the 11-member board of directors for